Vardenafil Oral Jelly

Vardenafil Oral Jelly (Vitara 20 mg Strawberry Jelly) - Product Information

Vardenafil Oral Jelly (Vitara 20 mg Strawberry Jelly) is a member of a class of medicines called phosphodiesterase type 5 inhibitors. This medicine is used for the treatment of erectile dysfunction in adult men, a condition which implies difficulties in getting or keeping an erection.
Vitara Strawberry Jelly (Vardenafil Oral Jelly) starts working about 15 minutes after consumption and will last for 3 hours to 4 hours.   In addition, the jelly sachets are more convenient to use than the traditional tablets. Each 5 gram sachet of Vitara Oral Jelly contains 20 mg of the active ingredient Vardenafil.
Vitara Strawberry Jelly is manufactured by HAB Pharmaceuticals & Research Ltd. (Signature) , India in the strength of 20 mg and packed in a 5 grams sachet.

We also have in stock Generic Tadalafil Tablets (Tadali) which is also used to treat the same indications.

What Is Better Sildenafil Oral Jelly Or Vardenafil Jelly?

Vardenafil Jelly will last for a similar amount of time as Sildenafil Oral Jelly(four to six hours). The main difference to Sildenafil is that Vardenafil tends to be less affected by food or alcohol so can be taken with meals.
There is also some evidence that Vardenafil oral jelly (Vitara 20mg strawberry jelly) is more effective in diabetics than other erectile dysfunction medicines. Men with diabetes were able to engage in successful intercourse on 33% of attempts with Vardenafil, compared with only 6% of attempts before treatment.

Is There A Generic Vardenafil?

The generic equivalent of Vardenafil have been launched in the 2.5 mg, 5 mg, 10 mg and 20 mg strengths many years back. Vitara 20 mg strawberry jelly is the generic version of Vardenafil in jelly form. Vardenafil is one of several erectile dysfunction medications that have recently become available in generic. Other similar medications include Sildenafil and Tadalafil.

Is Vardenafil Jelly More Potent Than Sildenafil Jelly ?

Vardenafil Jelly (Vitara 20 mg Strawberry Jelly) is almost 10 times more biochemically potent than Sildenafil Jelly, therefore a lower dose is needed to facilitate the penile erection, potentially resulting in less side effects. Selectivity is the ability of the medicine to attach to the specific enzyme PDE 5 found in penile tissues.

Name of the Drug

We supply original Vitara 20mg Strawberry Jelly manufactured by HAB Pharmaceuticals & Research Ltd. (Signature) , India.

Manufacturer of Vitara Strawberry Oral Jelly

HAB Pharmaceuticals & Research Ltd. (Signature)  
Website: www.habpharma.in

Active Ingredient present in Vitara Oral Jelly

The active ingredient present in Vitara oral Jelly is Vardenafil Hydrochloride Trihydrate. Each sachet of Vitara Oral Jelly contains 20 mg of Vardenafil.

Uses of Vitara Strawberry Jelly (Vardenafil Oral Jelly)

Vitara Strawberry Jelly (Vardenafil Oral Jelly) is used for the treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
Vitara Strawberry Jelly (Vardenafil Oral Jelly) takes about 30 minutes to start working and the effects last a little longer than Sildenafil, about 5 hours.

Vardenafil Oral Jelly (Vitara 20 mg Jelly) Dosage

The recommended Vardenafil Oral Jelly (Vitara 20 mg Jelly) dosage is orally once a day, with or without meals.
The recommended starting dose of Vardenafil is 5 mg in patients with moderate hepatic impairment (Child-Pugh B). The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg, hence Vardenafil 20 mg Oral Jelly is not suitable for this class of patients. Similar is the case If the patient is taking potent or moderate inhibitors of CYP3A4, as the dose of Vitara oral jelly has be adjusted downward.

Renal Impairment

Do not use Vitara 20 mg Strawberry Jelly in patients on renal dialysis, as Vardenafil has not been evaluated in this population.

How to take Vitara Strawberry Jelly

Vitara Strawberry Oral Jelly is usually taken as needed about 15 minutes before sexual activity. Open the sachet and consume entire contents. One sachet of Vitara Jelly is for one time use only. Use this medicine strictly under medical supervision.
Vitara Oral Jelly may be taken with or without meals. The full effect from one dose (one sachet 5 grams) will last for up to 3 to 4 hours, in some cases the effect can also last up to 24 hours. Some form of sexual stimulation is needed for an erection to happen with Vitara Oral Jelly.
Do not take Vitara Oral Jelly more than once a day i.e. at least 24 hours must pass before you take your next dose.

Is Vitara Strawberry Jelly Dangerous?

Vitara Strawberry Jelly (Vardenafil jelly) can cause your blood pressure to suddenly drop to an unsafe level if combined with other medications. A sudden decrease in blood pressure may cause dizziness or fainting and increases the risk for heart attack and stroke.
 

Is It Safe To Take Vitara Strawberry Jelly Everyday?

It is important that you do not take more than one Vitara Strawberry Jelly sachet per day. You also shouldn't take it every day. If you have sex several times a week, a daily treatment such as Tadalafil 5 mg (Tadalista Tablets by Fortune HealthCare) once daily may suit your needs better.
 

Vardenafil Oral Jelly (Vitara Jelly) Storage

Store at controlled room temperature (59°F to 86°F, 15°C to 30°C). Keep in a cool, dark and dry place. Protect from light. Keep out of reach of children.

Vitara Oral Jelly Contraindications

Vitara Oral Jelly is contraindicated in persons with a hypersensitivity (allergy) to Vardenafil or any of the other ingredients of this medicine.

Administration of Vitara Jelly with nitrates (either regularly and/or intermittently) and nitric oxide donors is contraindicated. Consistent with the effects of PDE5 inhibition on the nitric oxide/cyclic guanosine monophosphate pathway, PDE5 inhibitors, including Vitara 20mg Oral Jelly, may potentiate the hypotensive effects of nitrates. A suitable time interval following dosing of Vitara Strawberry Jelly for the safe administration of nitrates or nitric oxide donors has not been determined.
 

Warnings and Precautions

A medical history and physical examination should be undertaken to diagnose erectile dysfunction and determine potential underlying causes, before pharmacological treatment is considered.
Prior to initiating any treatment for erectile dysfunction, physicians should consider the cardiovascular status of their patients, since there is a degree of cardiac risk associated with sexual activity. Vardenafil has vasodilator properties, resulting in mild and transient decreases in blood pressure.
Patients with left ventricular outflow obstruction, e.g., aortic stenosis and idiopathic hypertrophic subaortic stenosis, can be sensitive to the action of vasodilators including Type 5 phosphodiesterase inhibitors. The other warnings and precautions when using Vardenafil Oral Jelly (Vitara 20mg Strawberry Jelly) are:

• Cardiovascular Effects: Patients should not use Vitara oral jelly if sex is inadvisable due to cardiovascular status.
• Risk of Priapism: In the event that an erection lasts more than 4 hours, the patient should seek immediate medical assistance.
• Effects on the Eye: Patients should stop use of Vitara oral jelly, and seek medical attention in the event of sudden loss of vision in one or both eyes, which could be a sign of nonarteritic anterior ischemic optic neuropathy (NAION). Vitara oral jelly should be used with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Patients with a "crowded" optic disc may also be at an increased risk of NAION.
• Sudden Hearing Loss: Patients should stop Vitara oral jelly and seek medical attention in the event of sudden decrease or loss in hearing.
• Alpha-Blockers: Caution is advised when PDE5 inhibitors are co­administered with alpha-blockers. In some patients, concomitant use of these two drug classes can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting).
• QT Prolongation: Patients with congenital QT syndrome or taking class IA or III antiarrhythmics should avoid using Vitara oral jelly (Vardenafil jelly)

Vardenafil Oral Jelly (Vitara 20 mg Strawberry Jelly) and Alcohol

Vardenafil (Vitara 20 mg Strawberry Jelly) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person). Alcohol and vardenafil plasma levels were not altered when dosed simultaneously.

Antihypertensives and Vitara 20 mg Strawberry Jelly

Vitara 20 mg Strawberry Jelly may add to the blood pressure lowering effects of antihypertensive agents. In a clinical pharmacology study of patients with erectile dysfunction, single doses of Vardenafil 20 mg caused a mean maximum lowering in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure took place between 1 and 4 hours after dosing.

Vardenafil Oral Jelly (Vitara Jelly) Side Effects

Most common side effects reported by 2% or more of patients undergoing treatment with Vardenafil (Vitara oral jelly) are headache, flushing, nasal congestion, dyspepsia, sinusitis, flu syndrome, dizziness, increased creatine kinase, nausea, back pain.
The following section identifies additional, less frequent side effects, with an incidence rate of less than 2% that were reported during the clinical development of Vardenafil tablets and vardenafil orally disintegrating tablets. Excluded from this list are those adverse reactions that are infrequent and minor, those events that may be commonly observed in the absence of drug therapy, and those events that are not reasonably associated with the medicine:

• Body as a whole: allergic edema and angioedema, feeling unwell, allergic reactions, chest pain
• Auditory: tinnitus, vertigo
• Cardiovascular: palpitation, tachycardia, angina pectoris, myocardial infarction, ventricular tachyarrhythmias,hypotension
• Digestive: nausea, gastrointestinal and abdominal pain, dry mouth, diarrhea, gastroesophageal reflux disease, gastritis, vomiting, increase in transaminases
• Musculoskeletal: increase in creatine phosphokinase (CPK), increased muscle tone and cramping, myalgia
• Nervous: paresthesia and dysesthesia, somnolence, sleep disorder, syncope, amnesia, seizure
• Respiratory: dyspnea, sinus congestion
• Skin and appendages: erythema, rash
• Ophthalmologic: visual disturbance, ocular hyperemia, visual color distortions, eye pain and eye discomfort, photophobia, increase in intraocular pressure, conjunctivitis
• Urogenital: increase in erection, priapism

Overdose of Vitara Strawberry Jelly (Vardenafil Oral Jelly)

Symptoms of a Vardenafil overdose are not known, but are likely to include chest pain, back pain, dizziness, an irregular heartbeat and abnormal vision.
The maximum dose of Vardenafil (Vitara Oral Jelly) for which human data are available is a single 120 mg dose administered to healthy male volunteers. The majority of these subjects experienced reversible back pain/myalgia and/or "abnormal vision." Single doses up to 80 mg vardenafil and multiple doses up to 40 mg Vardenafil administered once daily over 4 weeks were tolerated without producing serious adverse side effects. When 40 mg of vardenafil was administered twice daily, cases of severe back pain were observed. No muscle or neurological toxicity was identified.
In cases of Vitara Jelly overdose, standard supportive measures should be taken as required. Renal dialysis will not accelerate clearance as Vardenafil is highly bound to plasma proteins and not significantly eliminated in the urine.

Vardenafil (Vitara Oral Jelly) During Pregnancy

Vardenafil (Vitara Oral Jelly) is classified by the US FDA as Pregnancy Category B. Vardenafil (Vitara Oral Jelly) is not indicated for use in women. There are no studies of Vardenafil use in pregnant women.
No evidence of specific potential for teratogenicity, embryotoxicity or fetotoxicity was observed in rats and rabbits that received vardenafil at up to 18 mg/kg/day during organogenesis.
This dose is approximately 100 fold (rat) and 29 fold (rabbit) greater than the AUC values for unbound Vardenafil and its major metabolite in humans given the maximum recommended human dose (MRHD) of 20 mg.
 

Vardenafil (Vitara Oral Jelly) During Nursing

Vardenafil (Vitara Oral Jelly) is not indicated for use in women. It is not known if Vardenafil is excreted in human breast milk.
Vardenafil was secreted into the milk of lactating rats at concentrations approximately 10-fold greater than found in the plasma.
Following a single oral dose of 3 mg/kg, 3.3% of the administered dose was excreted into the milk within 24 hours.
 

Buy Vardenafil 20 mg Oral Jelly Online at Only $1.03 per Sachet of 5g

You can buy Vardenafil 20 mg Oral Jelly online from Clear Sky Pharmacy at a cheap price. Vitara Strawberry Jelly is manufactured by HAB Pharmaceuticals & Research Ltd. (Signature) , India in the strength of 20 mg and packed in a 5 grams sachet. The 20 mg jelly costs only $1.03 per unit when you place an order for 350 sachets.

Disclaimer

The above information is provided to the best of our knowledge and in good faith, it is without a warrant of any kind, expressed or implied.

Shipping Restriction